Anne W. Beaven

Anne Beaven, MD, is a UNC Lineberger Comprehensive Cancer Center member, an Associate Professor, and Director of the Lymphoma Program. Beaven’s research primary focuses on therapies in patients with lymphoma.

MD
Director, Lymphoma Program; Associate Professor
UNC-Chapel Hill
Clinical Research
Division of Hematology/Oncology

Area of Interest

I specialize in the treatment of patients with all types of lymphoma, including B and T-cell non-Hodgkin lymphoma subtypes and Hodgkin lymphoma. Cutaneous (skin) lymphomas, such as mycosis fungoids and Sezary syndrome, are of special interest to me. I also co-lead with Edith Bowers, MD, in dermatology, a multidisciplinary cutaneous lymphoma clinic.

In addition to taking care of patients in clinic, I develop and manage clinical trials for patients with lymphoma. I am heavily involved in the development of the UNC Lineberger CAR-T therapy program. This is an exciting approach that uses a patient’s own immune system to help fight their lymphoma.

Awards and Honors

  • Alliance Lymphoma Leadership Committee member, 2016-present
  • Lymphoma Research Foundation’s Mantle Cell Consortium member, 2014-present
  • Howard Hughes Grant to fund summer research in Chemistry, Wesleyan University, 1992
  • ASH Advocacy Leadership Institute, Washington DC Participant, October 2014
  • Department of Medicine Faculty Development Academy in Clinical/Health Services Research, Duke University Fellow, 2011-2013
  • T Cell Lymphoma Consortium member, 2010-present
  • American Society of Clinical Oncology member, 2005-present
  • Fellow, Clinical Research Curriculum NIH K30 HL04127 (David Ransohoff, PI), UNC-Chapel Hill, 2005-2007
  • American Society of Hematology member, 2004-present
  • Fellowship in Hematology/Oncology NIH T32 HL007149 (Beverly Mitchell, PI), UNC-Chapel Hill, 2004-2006

Find publications on PubMed

Anne Beaven